首页> 美国卫生研究院文献>EBioMedicine >Bone marrow mesenchymal stem cells combined with ultra-purified alginate gel as a regenerative therapeutic strategy after discectomy for degenerated intervertebral discs
【2h】

Bone marrow mesenchymal stem cells combined with ultra-purified alginate gel as a regenerative therapeutic strategy after discectomy for degenerated intervertebral discs

机译:骨髓间充质干细胞联合超纯海藻酸盐凝胶作为椎间盘退变椎间盘切除术后的再生治疗策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Because the regenerative ability of intervertebral discs (IVDs) is restricted, defects caused by discectomy may induce insufficient tissue repair leading to further IVD degeneration. An acellular bioresorbable biomaterial based on ultra-purified alginate (UPAL) gel was developed to fill the IVD cavity and prevent IVD degeneration. However, an acellular matrix-based strategy may have limitations, particularly in the elderly population, who exhibit low self-repair capability. Therefore, further translational studies involving product combinations, such as UPAL gel plus bone marrow-derived mesenchymal stem cells (BMSCs), are required to evaluate the regenerative effects of BMSCs embedded in UPAL gel on degenerated IVDs.
机译:由于椎间盘(IVD)的再生能力受到限制,因此由椎间盘切除术引起的缺损可能会导致组织修复不足,从而导致IVD进一步变性。开发了一种基于超纯藻酸盐(UPAL)凝胶的无细胞生物可吸收生物材料,可填充IVD腔并防止IVD变性。但是,基于脱细胞基质的策略可能会有局限性,特别是在自我修复能力较低的老年人群中。因此,需要进一步的翻译研究,涉及产品组合,例如UPAL凝胶加上骨髓源性间充质干细胞(BMSC),以评估UPAL凝胶中包埋的BMSC对变性IVD的再生作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号